NRICM101
Traditional Chinese medicine formula to target COVID-19
Nº Q105252811 ★★★
Rare · History
NRICM101
Traditional Chinese medicine formula to target COVID-19
NRICM101 (Chinese: 清冠一號; pinyin: Qīngguàn yī hào), is a treatment for COVID-19 developed in Taiwan using Traditional Chinese Medicine (TCM), created by the National Research Institute of Chinese Medicine (NRICM), a governmental body of Taiwan. The prescription has gained legal approval in several countries, the first TCM recipe to do so for COVID-19 treatment.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
NRICM101 (Chinese: 清冠一號; pinyin: Qīngguàn yī hào), is a treatment for COVID-19 developed in Taiwan using Traditional Chinese Medicine (TCM), created by the National Research Institute of Chinese Medicine (NRICM), a governmental body of Taiwan. The prescription has gained legal approval in several countries, the first TCM recipe to do so for COVID-19 treatment. In its native Taiwan, the treatment is used in conjunction with vaccinations. Amongst the formulations available are RespireAid from Sun Ten, and COVRelief from Chuang Song Zong. The formula is provided in granule form, which is common for Chinese patent medicine.
Text: Wikipédia, CC BY-SA 4.0. · Image: Rebiocadd (CC BY-SA 4.0) ·
